← Back to Nuqta Atlas
Editorially curated · ae-national-sars-cov2-genomic-surveillance
UAE SARS-CoV-2 Genomic Surveillance Project
Coordinated national viral sequencing and variant-surveillance system combining diagnostic laboratories, sentinel sampling, and border/port surveillance.
01 / Project overview
What the record establishes.
- Geographic scope
- All seven emirates; centrally coordinated from Abu Dhabi
- Project type
- national pathogen genomic surveillance
- Research domain
- infectious disease genomics and public health
- Years
- 2021–2022
- Lifecycle status
- completed pandemic surveillance phases
- Status basis
- The peer-reviewed program report documents central initiation in January 2021, four surveillance phases, and coverage of all seven emirates.
- Status evidence date
- 2023-02-01
- Scale
- Four operational phases spanning the seven emirates; sample totals varied by phase and are reported in the program paper.
02 / Organizations and population
Who and what the project connects.
- Lead organizations
- Abu Dhabi Public Health Centre
- Partner organizations
- Department of Health - Abu Dhabi · national and private diagnostic laboratories · airports and ports
- Organism / population
- SARS-CoV-2-positive clinical samples in the UAE
03 / Data and access
What exists and how it can be reached.
Data types
- viral whole-genome sequencing
- variant surveillance
- clinical sampling
- travel and port sampling
- epidemiological data
Data access
Aggregate results in the publication; sequence access follows the paper's deposition statements.
Identifiers
No public accession or identifier is listed for this record.
04 / Evidence and provenance
Why the record is included.
Inclusion basis
Centrally coordinated national, multi-phase pathogen-genomics surveillance program.
Editorial note
Successor/umbrella relative to early Dubai sequencing; phases should not be counted as separate projects.
Sources
- primary record source Verified 2026-08-15
Release v0.2.0